COVID-19 Na'urar Gwajin Saurin Antigen (Colloidal Gold)
Iyakance
1.Wannan reagent ana amfani dashi kawai don ganewar asali na in vitro.
2.Wannan reagent ana amfani dashi kawai don gano ɗan adam hanci swabs / oropharyngeal swabs samfurin. Sakamakon wasu samfurori na iya zama kuskure.
3.Wannan reagent ana amfani dashi ne kawai don gano na'urar kuma baya iya gano matakin novel corona virus antigen a cikin samfurin.
4.This reagent ne kawai na asibiti karin bincike kayan aiki. Idan sakamakon ya tabbata, ana ba da shawarar yin amfani da wasu hanyoyin don ƙarin bincike a cikin lokaci kuma ganewar asali na likita zai yi nasara.
5.Idan sakamakon gwajin ya kasance mara kyau kuma alamun asibiti sun ci gaba. Ana ba da shawarar maimaita samfur ko amfani da wasu hanyoyin gwaji don gwaji. Wani mummunan sakamako ba zai iya hana yuwuwar fallasa ko kamuwa da cutar ta SARS-CoV-2 a kowane lokaci ba.
6.Sakamakon gwaje-gwajen na'urorin gwajin na likitoci ne kawai, kuma bai kamata a yi amfani da su azaman tushen kawai don ganewar asibiti ba. Ya kamata a yi la'akari da kulawar asibiti na marasa lafiya a hade tare da alamun su / alamun su, tarihin likita, sauran gwaje-gwajen dakin gwaje-gwaje da martanin jiyya, da dai sauransu.
7.Due ga iyakance na gano reagent hanya, da iyaka ganewa na wannan reagent ne kullum m fiye da na nucleic acid reagents. Don haka, ma'aikatan gwajin ya kamata su mai da hankali sosai ga sakamako mara kyau kuma suna buƙatar haɗa wasu sakamakon gwajin don yin cikakken hukunci. Ana ba da shawarar yin amfani da gwajin nucleic acid ko keɓewar ƙwayoyin cuta da hanyoyin gano al'ada don duba mummunan sakamako waɗanda ke da shakku.
8.Sakamakon gwaji mai kyau ba ya ware haɗin gwiwa tare da sauran ƙwayoyin cuta.
9.Karya sakamako mara kyau na iya faruwa lokacin da matakin antigen SARS-CoV-2 a cikin samfurin ya yi ƙasa da iyakar gano kayan ko tarin samfuran da sufuri bai dace ba. Don haka, ko da sakamakon gwajin ba shi da kyau, ba za a iya kawar da yiwuwar kamuwa da cutar SARS-CoV-2 ba.
10. Kyawawan dabi'un tsinkaya masu kyau da mara kyau sun dogara sosai akan yawan adadin. Sakamakon gwaji mai kyau yana iya wakiltar sakamako mai kyau na karya yayin lokutan kankanin / babu ayyukan SARS-CoV-2 lokacin da cutar ta yi ƙasa. Sakamakon gwaji mara kyau na ƙarya yana da yuwuwa lokacin da yaduwar cutar da SARS-CoV-2 ke haifarwa ya yi yawa.
11.Nazarin yuwuwar sakamako mara kyau na karya:
(1) Tarin samfurori marasa ma'ana, sufuri da sarrafawa, ƙananan ƙwayoyin cuta a cikin samfurin, babu sabon samfurin ko daskarewa da narke hawan keke na samfurin na iya haifar da sakamako mara kyau.
(2) Canje-canje na kwayar cutar kwayar cutar kwayar cutar zai iya haifar da canje-canje a cikin masu ƙayyade antigenic, wanda zai haifar da sakamako mara kyau.
(3) Binciken kan SARS-CoV-2 bai kasance cikakke sosai ba; kwayar cutar na iya rikidewa kuma ta haifar da bambance-bambance don mafi kyawun lokacin samfur (mafi girman ƙwayar cuta) da wurin yin samfur. Sabili da haka, ga mai haƙuri ɗaya, za mu iya tattara samfurori daga wurare masu yawa ko biyo baya don sau da yawa rage yiwuwar sakamako mara kyau na ƙarya.
12.Monoclonal rigakafi na iya kasa gano, ko gano tare da ƙarancin hankali, ƙwayoyin cuta na SARS-CoV-2 waɗanda suka sami ƙananan canje-canjen amino acid a cikin yankin epitope da aka yi niyya.
